Ossfila is a leading brand that specializes in medical grade bioactive biomaterials for 3D printed medical implants. With their innovative product, Bonlecule, they have revolutionized the field of medical bioactive materials. Ossfila offers a range of products and services to cater to the needs of the medical industry.

Their flagship product, Bonlecule, is a bioactive filament specifically designed for 3D printing. It is the first commercially available hydroxyapatite enhanced bioactive FDM filament in the world. This filament can be used to create bioactive implants that integrate seamlessly with the human body.

Ossfila also provides one-stop production, packaging, and sterilization services for these implants, ensuring the highest standards of quality and safety. In addition, Ossfila offers patient-specific 3D printed implants, allowing for customized solutions tailored to individual needs. The company prides itself on its fast turnaround time, with the entire process—from obtaining CT images of the bone to 3D printing the missing piece—taking less than a week.

Ossfila's cutting-edge technology and dedication to research and development set them apart from their competitors. They are supported by the Hong Kong SAR Government R&D research grants and collaborate closely with regulators, medical professionals, and universities to ensure their products meet the highest standards. To experience the transformative power of Ossfila's bioactive materials, customers can conveniently order Bonlecule online.

For personalized 3D printed implants, their sales representatives are ready to assist. Join Ossfila in reshaping the future of medical implants and enhancing the quality of life for patients worldwide